IL-17 plays a role in respiratory syncytial virus-induced lung inflammation and emphysema in elastase and LPS-injured Mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 58, Issue 6, 2018, Pages 717-726

  Mebratu, Yohannes A ^a   Tesfaigzi, Yohannes ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Elastase; Emphysema; IL 17; LPS; Respiratory syncytial virus

Indexed keywords

CXCL1 CHEMOKINE; CYTOKINE; ELASTASE; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; INTERFERON; INTERLEUKIN 17; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; IL17A PROTEIN, MOUSE; PANCREATIC ELASTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFLAMMATORY CELL; LUNG ALVEOLUS CELL; LUNG EMPHYSEMA; MOUSE; MUCOUS CELL; NONHUMAN; PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRAL CLEARANCE; ANIMAL; C57BL MOUSE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HYPERPLASIA; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; VIROLOGY; VIRUS PNEUMONIA;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HYPERPLASIA; INTERLEUKIN-17; LIPOPOLYSACCHARIDES; LUNG; MICE, INBRED C57BL; PANCREATIC ELASTASE; PNEUMONIA, VIRAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 85048237324     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2017-0265OC     Document Type: Article

References (48)

1. Miniño AM, Xu J, Kochanek KD. Deaths: preliminary data for 2008. Natl Vital Stat Rep 2010;59:1-52.
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765-773.
3. Awji EG, Seagrave JC, Tesfaigzi Y. Correlation of cigarette smoke-induced pulmonary inflammation and emphysema in C3H and C57Bl/6 mice. Toxicol Sci 2015;147:75-83.
4. Awji EG, Chand H, Bruse S, Smith KR, Colby JK, Mebratu Y, et al. Wood smoke enhances cigarette smoke-induced inflammation by inducing the aryl hydrocarbon receptor repressor in airway epithelial cells. Am J Respir Cell Mol Biol 2015;52:377-386.
5. Xia M, Viera-Hutchins L, Garcia-Lloret M, Noval Rivas M, Wise P, McGhee SA, et al. Vehicular exhaust particles promote allergic airway inflammation through an aryl hydrocarbon receptor-notch signaling cascade. J Allergy Clin Immunol 2015;136:441-453.
6. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-2365.
7. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117(5 suppl 2):398S-401S.
8. Wright JL, Churg A. Animal models of cigarette smoke-induced COPD. Chest 2002;122(6 suppl):301S-306S.
9. Criado G, Simelyte E, Inglis JJ, Essex D, Williams RO. Indoleamine 2, 3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis. Arthritis Rheum 2009;60:1342-1351.
10. McAleer JP, Kolls JK. Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense. Immunol Rev 2014;260:129-144.
11. Chang Y, Nadigel J, Boulais N, Bourbeau J, Maltais F, Eidelman DH, et al. CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respir Res 2011;12:43.
12. Chang Y, Al-Alwan L, Audusseau S, Chouiali F, Carlevaro-Fita J, Iwakura Y, et al. Genetic deletion of IL-17A reduces cigarette smoke-induced inflammation and alveolar type II cell apoptosis. Am J Physiol Lung Cell Mol Physiol 2014;306:L132-L143.
13. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010;129:311-321.
14. Kim V, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:478-485.
15. Mebratu YA, Smith KR, Agga GE, Tesfaigzi Y. Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses. Respir Res 2016;17:75.
16. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115:829-835.
17. Ishii T, Hosoki K, Nikura Y, Yamashita N, Nagase T, Yamashita N. IFN regulatory factor 3 potentiates emphysematous aggravation by lipopolysaccharide. J Immunol 2017;198:3637-3649.
18. Beckett EL, Stevens RL, Jarnicki AG, Kim RY, Hanish I, Hansbro NG, et al. A new short-Term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. J Allergy Clin Immunol 2013;131:752-762.
19. Sajjan U, Ganesan S, Comstock AT, Shim J, Wang Q, Nagarkar DR, et al. Elastase-And LPS-exposed mice display altered responses to rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2009;297: L931-L944.
20. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995;3: 811-821.
21. Khader SA, Gaffen SL, Kolls JK. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2009;2:403-411.
22. Chen K, Pociask DA, McAleer JP, Chan YR, Alcorn JF, Kreindler JL, et al. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One 2011;6:e20333.
23. Tesfaigzi Y. Roles of apoptosis in airway epithelia. Am J Respir Cell Mol Biol 2006;34:537-547.
24. Foronjy RF, Taggart CC, Dabo AJ, Weldon S, Cummins N, Geraghty P. Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors. Mucosal Immunol 2015;8:161-175.
25. Maeno T, Houghton AM, Quintero PA, Grumelli S, Owen CA, Shapiro SD. CD81 T cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J Immunol 2007;178: 8090-8096.
26. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001;17:946-953.
27. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1304-1309.
28. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003;22: 672-688.
29. Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, Pleschka S, et al. Lung epithelial apoptosis in influenza virus pneumonia: The role of macrophage-expressed TNFrelated apoptosis-inducing ligand. J Exp Med 2008;205: 3065-3077.
30. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233-240.
31. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Pagé N, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001;108: 430-438.
32. Kolls JK, Khader SA. The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev 2010;21:443-448.
33. Zhang X, Jin J, Tang Y, Speer D, Sujkowska D, Markovic-Plese S. IFNb1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J Immunol 2009;182: 3928-3936.
34. Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, et al. Role of a transductional-Transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 2004;101:15416-15421.
35. Lukacs NW, Smit JJ, Mukherjee S, Morris SB, Nunez G, Lindell DM. Respiratory virus-induced TLR7 activation controls IL-17-Associated increased mucus via IL-23 regulation. J Immunol 2010;185: 2231-2239.
36. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008;295: L1-L15.
37. Kurimoto E, Miyahara N, Kanehiro A, Waseda K, Taniguchi A, Ikeda G, et al. IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice. Respir Res 2013;14:5.
38. de Almeida Nagata DE, Demoor T, Ptaschinski C, Ting HA, Jang S, Reed M, et al. IL-27R-mediated regulation of IL-17 controls the development of respiratory syncytial virus-Associated pathogenesis. Am J Pathol 2014;184:1807-1818.
39. Hashimoto K, Graham BS, Ho SB, Adler KB, Collins RD, Olson SJ, et al. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. Am J Respir Crit Care Med 2004;170:306-312.
40. Fujii U, Miyahara N, Taniguchi A, Waseda K, Morichika D, Kurimoto E, et al. IL-23 is essential for the development of elastase-induced pulmonary inflammation and emphysema. Am J Respir Cell Mol Biol 2016;55:697-707.
41. Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, Enelow R, et al. Cigarette smoke selectively enhances viral PAMP-And virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 2008;118:2771-2784.
42. Hoshino T, Kato S, Oka N, Imaoka H, Kinoshita T, Takei S, et al. Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Am J Respir Crit Care Med 2007;176:49-62.
43. Fujisawa T, Velichko S, Thai P, Hung LY, Huang F, Wu R. Regulation of airway MUC5AC expression by IL-1b and IL-17A; the NF-kB paradigm. J Immunol 2009;183:6236-6243.
44. Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP, Hershenson MB, et al. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011;179:248-258.
45. Shen N, Wang J, Zhao M, Pei F, He B. Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice. Inhal Toxicol 2011;23:212-218.
46. Isaacs A, Lindenmann J. Virus interference: I. The interferon. Proc R Soc Lond B Biol Sci 1957;147:258-267.
47. Hornung V, Schlender J, Guenthner-Biller M, Rothenfusser S, Endres S, Conzelmann KK, et al. Replication-dependent potent IFN-A induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J Immunol 2004;173:5935-5943.
48. Cormier SA, Shrestha B, Saravia J, Lee GI, Shen L, DeVincenzo JP, et al. Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection. J Virol 2014;88:9350-9360.